Charcot Foot 
(Charcot Neuroarthropathy)

Overview
Charcot foot, or Charcot neuroarthropathy, is a progressive, destructive condition of the bones, joints, and soft tissues of the foot and ankle that occurs in the setting of peripheral neuropathy.
It is characterized by inflammation, bone resorption, joint subluxation or dislocation, and eventual collapse of the foot architecture.
If not recognized and treated early, Charcot foot can lead to severe deformity, recurrent ulceration, infection, and amputation.
This condition most commonly affects people with diabetes mellitus, but can also occur in patients with other causes of neuropathy such as alcoholism, leprosy, or spinal cord injury.


Etiology and Pathogenesis
Underlying Cause

• Peripheral neuropathy is the central risk factor. Loss of protective sensation and impaired autonomic regulation lead to unrecognized trauma and abnormal microvascular responses.

Pathophysiology
The exact mechanism is multifactorial and still under investigation, but two main hypotheses are described:

1. Neurotraumatic Theory
   • Loss of protective sensation → repetitive, unrecognized trauma → microfractures and joint instability → progressive destruction.
2. Neurovascular Theory
   • Autonomic neuropathy → increased peripheral blood flow → osteoclastic bone resorption and weakening → pathologic fractures and dislocations.

These mechanisms interact with mechanical loading and inflammation, producing osteolysis, joint collapse, and foot deformity.
Risk Factors

• Long-standing diabetes with peripheral neuropathy
• History of foot trauma, ulceration, or surgery
• Chronic kidney disease or renal transplantation
• Alcoholism, syphilis, leprosy, spinal cord disorders (less common today)

Clinical Presentation and Diagnosis
Early Signs

• Red, hot, swollen foot often mistaken for infection, cellulitis, or gout.
• Minimal or no pain despite significant swelling (due to neuropathy).
• Bounding pulses and increased skin temperature (3–7 °C higher than the contralateral foot).

Late Signs

• Midfoot collapse (rocker-bottom deformity)
• Joint instability or dislocation
• Bony prominences leading to pressure points and ulceration.

Imaging

• Plain radiographs: Early films may be normal; later stages show fragmentation, subluxation, and collapse.
• MRI: Detects bone marrow edema and early changes before X-ray findings.
• Bone scans: Helpful to distinguish Charcot from infection if diagnosis is uncertain.
• Eichenholtz classification:
  • Stage 0: Clinical inflammation without radiographic change.
  • Stage 1: Fragmentation and joint dislocation.
  • Stage 2: Coalescence of fragments.
  • Stage 3: Consolidation and remodeling.

Early diagnosis—particularly at Stage 0 or 1—is critical to prevent irreversible deformity.


Treatment
Management goals are to halt the destructive process, maintain foot shape, and prevent ulceration or amputation.
Acute Phase (Stage 0–1)

• Immediate off-loading and immobilization are the cornerstone:
  • Total contact cast (TCC) is the gold standard.
  • Removable cast walkers or Charcot restraint orthotic walker (CROW) as alternatives when TCC is not feasible.
• Strict non–weight bearing until edema, warmth, and radiographic activity subside (often 3–6 months or longer).
• Monitor skin temperature and radiographs regularly to assess activity.

Coalescence and Remodeling Phase (Stage 2–3)

• Gradual transition to protected weight bearing with custom-molded shoes, orthoses, or CROW boots.
• Ongoing podiatric care to prevent ulceration and manage pressure points.

Adjunctive and Pharmacologic Therapy

• Limited evidence supports bisphosphonates (e.g., pamidronate), calcitonin, or denosumab to reduce bone turnover, but these are not standard of care.
• Optimize glycemic control, vitamin D, calcium, and bone health.

Surgical Management
Indicated for:

• Severe deformity with recurrent ulceration.
• Instability not controllable with bracing.
• Chronic infection or non-healing ulcers.

Procedures include:

• Exostectomy for bony prominences.
• Realignment osteotomy or arthrodesis (internal or external fixation) for severe deformity.
• Limb salvage reconstruction in select advanced cases.

Expectations and Prognosis

• Early recognition and off-loading can arrest disease progression and preserve foot architecture.
• Total contact casting in the acute phase typically continues for 3–6 months, sometimes longer.
• After consolidation, custom footwear and lifelong foot surveillance are required to prevent recurrence or ulceration.
• Delayed or missed diagnosis can lead to rocker-bottom deformity, chronic ulcers, osteomyelitis, and amputation.
• Mortality risk increases with severe infection or major amputation, underscoring the importance of early diagnosis and multidisciplinary care.

Key References (Peer-Reviewed)

1. Petrova NL, Edmonds ME. Charcot neuro-osteoarthropathy—current standards. Diabetes Metab Res Rev. 2008;24(Suppl 1):S58–S61.
2. Rogers LC, Frykberg RG, Armstrong DG, et al. The Charcot foot in diabetes. Diabetes Care. 2011;34(9):2123–2129.
3. Pinzur MS. Current concepts review: Charcot arthropathy of the foot and ankle. Foot Ankle Int. 2007;28(8):952–959.
4. Wukich DK, Raspovic KM, Hobizal KB, Rosario BL. Radiographic analysis of diabetic Charcot foot. Foot Ankle Int. 2013;34(6):833–840.
5. Game FL, Attinger C, Hartemann A, et al. IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab Res Rev. 2016;32(Suppl 1):45–74.
6. Armstrong DG, Todd WF, Lavery LA, Harkless LB, Bushman TR. The natural history of acute Charcot’s arthropathy in a diabetic foot specialty clinic. Diabet Med. 1997;14(5):357–363.

Summary
Charcot foot (Charcot neuroarthropathy) is a progressive, destructive condition of the bones and joints of the neuropathic foot, most commonly associated with diabetes.
It begins with inflammation and bone weakening, progresses to joint collapse, and, if untreated, leads to severe deformity and ulceration.
Early recognition and prompt immobilization/off-loading are critical to halting progression.
Once stabilized, long-term care includes custom footwear, patient education, and regular foot surveillance.
With timely, multidisciplinary management, many patients can avoid ulceration, infection, and amputation.
 

Recommended DIY Products